美国 · 平台与数据 · Seeking Alpha

Boston Scientific anticipates Q4 2026 organic revenue down 3% to down 1% and adjusted EPS $0.77-$0.79 amid cyber and EP/WATCHMAN pressure

来源：Seeking Alpha · 美国 1 小时前

在 Seeking Alpha 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (seekingalpha.com)

推荐阅读

O-I Glass (NYSE:OI) Shares Gap Down on Disappointing Earnings

The U.S. government will no longer penalize American companies for making six popular peptides

NextTrip at Planet MicroCap Showcase: Toronto 2026: media push grows

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Market News

ATOSS Software Q3 2026 Earnings Call Is Live